$TDY

Is Teledyne Technologies (TDY) Fairly Valued As It Buys Varex Imaging?

Simply Wall St reports Teledyne Technologies (TDY) agreed to buy Varex Imaging in an all-cash deal valued at about $1.1b, offering $18.90 per Varex share. The article cites TDY stock performance and a “fair value” view of about $753 versus a $690.25 close, noting valuation and margin risks.

Original reporting
Published Aug 11, 2026, 7:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 6:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMergers & acquisitions
Primary signal
$TDY
Bullish
medium confidence
Mentioned
$TDY · $VREX
Relevance
7/10
alphai data visualization · based on simplywall.st
Decision brief

The 30-second read

$TDYBullishMed
01

Why it matters

For traders, the actionable element is the disclosed all-cash deal value (~$1.1B) and offer price ($18.90 per Varex share), which can drive repricing of TDY’s growth and margin expectations. The remainder is valuation framing (fair value vs current price, P/E comparisons) and risk flags (tariffs, supply chain costs, slower organic sales).

02

Market read

Deal terms plus valuation debate can affect near-term positioning in TDY, especially for investors trading M&A and defense-linked industrial electronics exposure.

03

What to watch

Execution risk is not quantified here: integration costs, deal closing timing, and whether oncology-focused detector demand offsets any slower organic sales or tariff-driven cost inflation.

Relevance 7/10Novelty 6/10Timing: deal terms and valuation debate following the $1.1B acquisition announcement

Background

The piece centers on Teledyne Technologies’ acquisition of Varex Imaging and discusses valuation versus analyst targets and peers.

Company-level read

Ticker impact

$TDYBullishMedium confidence
Context

Teledyne agreed to buy Varex Imaging in an all-cash deal valued at about $1.1B, adding oncology-focused X-ray detectors.

Expected impact

Likely supports a bullish bias while deal terms are digested, but valuation risk remains if organic sales or margins disappoint.

Evidence & confidence

The article discloses the deal size and per-share price, then frames valuation versus peers and highlights specific risks (slower organic sales, margin pressure, tariffs/supply chain).

Market effects

Could reinforce investor focus on defense and imaging/instrumentation demand, and on M&A-driven portfolio expansion in industrial electronics.

No specific regional market effects are disclosed beyond global defense and aerospace spending references.

The thesis cites record-high global defense and aerospace spending, implying cross-border demand tailwinds for imaging-related suppliers.

Counterpoint

The stock may already price in the acquisition and defense tailwinds; the article notes TDY’s P/E is below some peers but still above a “fair” 25x, leaving downside if sentiment cools.

Key entities

  • Teledyne Technologies

    Subject of the article; agreed to acquire Varex Imaging in an all-cash ~$1.1B transaction.

  • Varex Imaging

    Acquired company; deal offers $18.90 per share and adds oncology-focused X-ray detectors to TDY.

Related articles

$TDYMed

Fitch upgrades Teledyne Technologies rating on strong cash flow

Fitch Ratings upgraded Teledyne Technologies Inc. (NYSE:TDY) long-term issuer default rating to BBB+ from BBB and raised its senior unsecured revolver and notes to BBB+ from BBB, with a Stable outlook. Fitch cited stronger free cash flow, low 2.0x EBITDA leverage, debt near $2.0B, and funded backlog about $5.0B. Fitch also referenced TDY’s $1.1B acquisition of Varex Imaging.

$VREXMed

Varex Imaging Corporation revenues hit USD 211M in Q3FY26

Varex Imaging reported unaudited Q3 FY2026 results: revenue of $211 million, GAAP gross margin 36% (non-GAAP 37%), GAAP operating margin 11% (non-GAAP 12%), and GAAP diluted EPS $0.37 (non-GAAP $0.31). Third-quarter revenues rose 4% YoY, with Medical $134 million and Industrial $77 million. The company received $17 million in U.S. Customs refunds tied to IEEPA tariffs.

$VREXMed

Varex Q3 FY2026 Results Show Revenue Growth and Margin Expansion Ahead of Teledyne Transaction

Varex Imaging (NASDAQ:VREX) reported Q3 FY2026 revenue of $211 million, up 4% year over year, with Industrial revenue at $77 million and Medical at $134 million. Non-GAAP gross margin rose to 37% from 34% and non-GAAP EPS increased to $0.31 from $0.13. Tariff refunds and customer reimbursements added about $10 million to gross profit. Varex cancelled its earnings call and declined guidance due to a pending Teledyne Technologies transaction.

$TDYMedAI 9/10

Teledyne agrees to acquire Varex Imaging for $1.1bn

Teledyne Technologies agreed to buy Varex Imaging in a cash deal valued at nearly $1.1 billion. Teledyne will pay $18.90 per Varex share, including equity awards and net debt as of April 3, 2026, subject to closing conditions. Completion is targeted for early 2027 after regulatory and stockholder approvals.

$HZOHighAI 9/10

MarineMax Leaps 46.1% After Announcing Deal

MarineMax shares rose 46.1% after the company agreed to be sold for about $1.5 billion in cash to a Blackstone portfolio company. Varex Imaging jumped 48.8% after Teledyne Technologies said it will buy it for $18.90 per share. The S&P 500, Dow, and Nasdaq fell slightly as Brent crude rose to $87.72.